Attached files
| file | filename |
|---|---|
| 10-K - AEOLUS PHARMACEUTICALS, INC. | v206778_10k.htm |
| EX-21.1 - AEOLUS PHARMACEUTICALS, INC. | v206778_ex21-1.htm |
| EX-31.2 - AEOLUS PHARMACEUTICALS, INC. | v206778_ex31-2.htm |
| EX-31.1 - AEOLUS PHARMACEUTICALS, INC. | v206778_ex31-1.htm |
| EX-32.1 - AEOLUS PHARMACEUTICALS, INC. | v206778_ex32-1.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statements of
Aeolus Pharmaceuticals, Inc. on Form S-8 (File Nos. 333-12923, 333-53017,
333-33636, 333-94169, 333-58754, 333-99421, 333-98635, 333-98637, 333-99421-99,
333-115499, 333-121424, 333-121425 and 333-141633), of our report dated December
28, 2010, appearing in the Annual Report on Form 10-K of Aeolus Pharmaceuticals,
Inc. for the year ended September 30, 2010, which includes an explanatory
paragraph expressing substantial doubt about the Company’s ability to continue
as a going concern.
/s/
Haskell & White LLP
HASKELL
& WHITE LLP
Irvine,
California
December
28, 2010